Publisher's Synopsis
Endovascular therapies for the management of stroke are sometimes perceived as similar to those used for coronary artery disease. Wrong. The technical difficulties encountered because of the vascular biomechanics of the cerebral arteries and extracranial vessels are a major challenge as compared to treating the coronary arteries. Intracranial atherosclerosis is a common cause of stroke, the most common life-threatening neurological disease. In Europe, North and South America, and Asia, stroke is the third leading cause of death. As all stroke patients are not suitable for endovascular revascularization (all endovascular treatments are customized), Dr Meyers and his superb multidisciplinary team of contributors examine the essentials of medical therapy and the latest pharmaceutical products available. Nonetheless, there is major emphasis on treatments borne of the latest micro-stent technology, which is hoped will improve the poor prognosis of patients with symptomatic intracranial stenoses
